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Outcome? 
I. Nyamekye*',  D. Costa 2, M. Raphael 1 and C.C.R. Bishop 1 
IVascular Unit and 2Institute of Nuclear Medicine, U.C.L. Hospitals NHS Trust, The Middlesex Hospital, 
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Objectives: Use of platelet deposition to predict failure following angiop]asty. 
Design: Prospective study of angioplasty patients in a 9 months urveillance period. 
Materials: Thirty-eight successful angioplasty patients. 
Methods: Autologous 111indium-labelled platelets were re-injected immediately after angioplasty. Gamma camera and 
probe measures of radioactivity were obtained daily for 2-4 days and compared to a reference site to obtain a radioactivity 
ratio. Patient follow up was with duplex and arteriography from day 0 to 9 months or at angioplasty failure. 
Results: Thirty-one patients remained asymptomatic; two developed acute occlusion and five developed restenosis. Platelet 
accumulation (increased mean radioactivity ratio) occurred at all angioptasty sites and was significantly higher after 
acute occlusion (camera: 2.93 and probe: 1.93) compared to asymptomatic patients (camera: 1.25 and probe: 1.15) and 
restenotic patients (camera: 1.31 and probe: 1.23). Radioactivity ratio was not different in patients who later developed 
restenosis. 
Conclusion: ~Indium platelet radioactivity effectively detected acute angioplasty reocclusions, but was unable to predict 
subsequent angioplasty restenosis. 
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Introduction 
Platelets may play a significant role in the development 
of experimental restenosis both directly, by thrombosis 
and indirectly, through the production of mediators 
which stimulate the development of fibrocellular in- 
timal hyperplasia. 1 Platelet derived growth factor, one 
such mediator is chemotactic for medial smooth 
muscle cells; it also interacts with insulin derived 
growth factor and thrombin to stimulate smooth 
muscle cell proliferation during the formation of in- 
timal hyperplasia. 2 Such smooth muscle cell migration 
and proliferation underlie the changes at the sites 
of anastomotic stenosis and angioplasty restenosis. 
l~Indium-labelled platelets permit clinical detection of 
thrombus and give an estimation of platelet dynamics. 
This radioactive tracer has demonstrated thrombus 
formation in native arteries and thrombosis and re- 
stenosis at arterial anastomotic sites. 3'4 
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The aim of this prospective clinical study was to 
assess the significance of acute platelet accumulation 
at angioplasty sites on angioplasty outcome by de- 
termining the influence of acute radioactivity detection 
from autologous 11~indium-labelled platelets. 
Materials and Methods 
Autologous platelets were harvested from 50 ml of 
venous blood and labelled by a standard technique and 
used to assess platelet accumulation after successful 
femoropopliteal rtery angioplasty. 5111Indium-labelled 
platelets were injected after completion of the an- 
gioplasty procedure, at the time of manual com- 
pression at the puncture site. Angioplasty surveillance 
was performed with ankle-brachial Doppler pressure 
indices (ABPI) and colour duplex imaging at 1, 2 and 
3 days and 1, 3, 6 and 9 months after angioplasty. 
The daily tests were done immediately before each 
radioactivity assessment. Patients were also assessed 
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by intravenous digital subtraction arteriography (IV- 
DSA) at 6 months or, if sooner, at the time of an- 
gioplasty failure. 
Activity was measured at the angioplasty site and 
at a similar position (of known arterial patency) in the 
opposite limb using a single probe and a medium field 
of view gamma camera. Counts were obtained at 1-3 h 
(day 0), 18-21 h (day 1), 40-44 h (day 2) and 64-68 h 
(day 3) after treatment as follows: For the probe studies, 
three measurements of radioactive counts were made 
over a 10 s period by holding the probe perpendicular 
to the skin surface and centred on permanent ink skin 
marks (placed at the time of angioplasty) over the 
treated site and then over the reference site. For the 
gamma camera, images were centred on the ink marks 
and the treated site was labelled with a cobalt-57 point 
source. The gamma image included both lower limbs 
from the symphysis pubis to the knees for superficial 
femoral artery lesions, and from the umbilicus to the 
mid-femoral region for iliac lesions. The cobalt mark 
was overlapped with the gamma camera images to 
facilitate identification of the exact treatment site. The 
gamma images alone (without he cobalt source) were 
then analysed using regions of interest (ROI) as fol- 
lows: a region of interest was drawn over the an- 
gioplasty site, and radioactivity counts were measured 
within the drawn area. The same region of interest 
was used to measure the activity from the reference 
artery. In order to eliminate the differences in back- 
ground radioactivities in different patients and at dif- 
ferent sites the ratio of counts (treated site vs. reference 
site) was calculated and used for comparison. Because 
the area of the angioplasty site was variable three 
variably sized boxes were drawn over the treated 
region in each patient and at each time point. Thus 
three consecutive measurements were made from the 
same image by the same observer using different ROI. 
The mean of the three ratios was calculated and called 
the radioactivity ratio (RR). Similar calculations were 
made for the probe counts. Thus, two RRs were ob- 
tained at each assessment time, one for the gamma 
camera and one for the single probe measurements. 
Radioactivity measurements were stopped when an 
occlusion was objectively demonstrated. 
Percent diameter stenosis (PDS) was measured from 
angiograms and duplex images as the ratio of the 
diameter eduction at the angioplasty site to the dia- 
meter of the 'normal' artery lumen (e.g. no lumen= 
100% diameter stenosis). Duplex diameters were as- 
sessed by measuring the colour-filled lumen on a 
longitudinal image of the artery. The point of max- 
imum systolic velocity at the angioplasty site was used 
and compared to a normal artery segment and at three 
different probe positions. This study was approved 
by the Joint UCL/UCH Committee on the Ethics of 
Human Research, Middlesex Hospital Clinical In- 
vestigations Panel. Informed written consent was ob- 
tained from all patients. 
Results 
Angioplasty procedures were performed in 38 patients 
with an age range from 42 to 80 years. There were 24 
men and 14 women. All patients had life-style limiting 
lower limb claudication and angiographically dem- 
onstrated stenoses (30) or occlusions (8). Patients were 
given prophylactic heparin (2000 units) and 75 mg of 
aspirin was given daily after angioplasty. Two patients 
reoccluded their angioplasty site within 24 h (1 dilated 
femoropopliteal stenosis and i dilated femoropopliteal 
occlusion). Five patients developed clinical angioplasty 
failure signalled by recurrence of symptoms and con- 
firmed by duplex and angiography. These all required 
re-intervention. Thirty-one patients remained 
asymptomatic during the 9 month follow-up period. 
The labelling efficiency was in the order of 80% and 
the average radioactivity administered topatients was 
16.5 MBq (range 14.1-21.6 MBq). There was pro- 
gressive reduction in the absolute daily radioactivity 
counts with time. Radioactivity measurements were 
highest at the initial measurement and there was pro- 
gressive reduction in absolute counts over subsequent 
days. All patients howed higher counts on the treated 
side than the normal side. The mean RRs with the 
probe were 1.15, 1.23 and 1.93 for asymptomatic 
patients, late angioplasty failures (restenosis) and acute 
reocclusions respectively. The camera values were 1.25, 
1.31, 2.93 for the same three groups. The increased 
activity after acute occlusion were significantly dif- 
ferent from those seen in asymptomatic patients and 
angioplasty failures (significant at 99% ANOVA) (Fig. 
2). The values were slightly higher for patients who 
developed restenosis than for asymptomatic patients 
but this did not reach statistical significance. 
The influence of other patient factors on the RR 
were also assessed and the data is summarised here: 
clinical factors (pre-angioplasty aspirin medication and 
smoking status), differences in the cannulation pro- 
cedure (guidewire, laser fibre-guided, laser-guided) 
and angiographic factors (degree of arterial trauma 
estimated from dissections and flaps, number of sten- 
oses treated and the length of lesion) showed no 
significant influence on RR for either camera or probe 
counts. RR showed a difference on camera count when 
angioplasty was performed for stenoses rather than 
occlusions. 
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Fig. 1. (a) lnIndium image obtained 1 day after left superficial femoral artery angioplasty in a patient with a patent angioplasty site. (b) 
~lIndium image obtained 1 day after angioplasty in a patient after left superficial femoral artery angioplasty, who has developed acute 
occlusion at the angioplasty site. Both images show increased radioactivity at the angiopIasty treated side (arrow) compared to the 
untreated side. There is greater adioactivity in the presence of acute occlusion. 
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Fig. 2. Radioactivity ratio (RR) and angioplasty outcome. (a) Graph showing radioactivity ratios (RR) measured by probe as a function 
of angioplasty outcome. (b) Graph showing radioactivity ratios (RR) measured by camera s a function of angioplasty outcome. Outcome 
groups are represented asfollows: 1 - reocclusion within 24 h, 2 - angioplasty failures (who required re-intervention between 1day and 
9 months, and 3 - patent arteries at 9 months. *Significant at 99% ANOVA. 
Discussion 
111Indium-platelet labelling is an established method for 
assessing platelet deposition in vivo. We have studied 
the effects of acute platelet deposition on angioplasty 
outcome by detecting 11~indium-platelet d position and 
showed that it did not predict angioplasty restenosis 
and this may have been due in part to bleeding into the 
arterial wall. A marked rise in radioactivity counts in 
our patients always coincided with acute angioplasty 
occlusion. These counts differed significantly from 
those patients who did not show acute occlusion. Radio- 
activity ratios were generally higher for camera meas- 
urements, where arterial site specificity was assured, 
than for probe measurements. Excluding the acute oc- 
clusions, rise in radioactivity counts were not different 
in patients whose angioplasty sites remained patent 
from those who developed symptoms because of re- 
stenosis, although there was a trend of slightly higher 
values in the latter. A larger study with greater statistical 
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power might reveal this difference to be significant, 
however, it is unlikely that such a difference would have 
any value in predicting outcome in individual patients. 
This was in agreement with experimental nd clinical 
reports which showed that reduction of platelet/vessel 
wall interactions did not influence restenosis. 4'5 Our 
findings, however, contradict previous studies with 
small patients numbers which reported localised in- 
crease in radioactivity after angioplasty to be predictive 
of restenosis. 8-~° 
The role of platelets in restenosis is complex and 
may not be easily explained by detection of platelet 
deposition at angioplasty sites. Angioplasty causes 
endothelial denudation which stimulates platelet ad- 
hesion and aggregation to the underlying sub- 
endothelial surface. Active chemotactic and mitogenic 
agents released uring this platelet reaction stimulates 
smooth muscle cell interactions involved in the for- 
mation of intimal hyperplasia, u Despite the role of 
platelets in these smooth muscle cell interactions, anti- 
platelet drugs such as aspirin and dypiridamol, platelet 
function inhibitors such as ticlopidine, and platelet 
anti-aggregates have all failed to reduce clinical re- 
stenosis. 12-~4 In addition, experimental studies of anti- 
platelet antibodies which have reduced thrombus 
formation have not influenced experimental restenosis. 
Monoclonal antiplatelet antibody induced thrombo- 
cytopenia caused marked reduction but did not com- 
pletely abolish experimental intimal hyperplasia or 
clinical restenosis. 15']6 Thus the role of adherent plate- 
lets at angioplasty sites in the subsequent formation 
of intimal hyperplasia remains unclear. 
The reasons why acute platelet detection does not 
signal later angioplasty restenosis are not understood. 
We speculate that the effective production of platelet 
stimulatory factors may be achieved by the initial layer 
of adhering platelets, and further platelet aggregation 
may be superfluous to the subsequent smooth muscle 
cell interactions. Also, many of the interacting platelet 
factors are produced by other cells such as endothelial 
cells, smooth muscle cell and monocyte-macrophages 
within the injured arterial wall so that platelets may 
not be essential for restenosis. 17
In this report H~indium-platelets detected acute oc- 
clusions although such failures occurred in only two 
of our primary angioplasty successes. This is the sub- 
ject of another report. 18 mIndium-platelet deposition 
failed to indicate the treatment method used at an- 
gioplasty. This probably reflects the fact that balloon 
dilatation, the major traumatic event, is common to 
all the procedures. These results contrast with Ram 
Mohan et al. and others who have reported an in- 
creased incidence of thrombosis for laser assisted bal- 
loon angioplasty. 9 
It is a criticism of the present report hat the number 
of acute and chronic angioplasty failures are small and 
our comments hould be viewed in this light. In this 
study of modest patient numbers we have found no 
evidence to support auseful role for mindium-platelets 
and radioactivity counts in predicting angioplasty re- 
stenosis. Thus it could offer no help in predicting 
patients for prophylactic therapy or for intensive an- 
gioplasty surveillance. Predictably, radioactivity 
counts detected all acute thrombotic occlusions. How- 
ever, platelet studies are expensive and are unlikely 
to have a useful clinical role because such occlusions 
are readily detected by duplex scanning. The number 
of patients who developed acute occlusion in this 
study were too small to allow meaningful conclusions 
on aetiological factors to be made. The process of 
mindium-platelet labelling and radioactivity detection 
is expensive and labour intensive and this method 
must now be considered to have a doubtful role in 
the study of angioplasty restenosis. 
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